Charta Health funding, valuation and investors

Product & use cases

Illustrative provider workflow grounded in Charta documentation: (1) connect to the organization's EHR; (2) ingest the clinical note and associated chart before billing; (3) compare documented care with payer, coding and specialty rules; (4) flag missing or unsupported diagnoses and coding exceptions; (5) clinician or coder reviews findings inside their EHR; (6) submit more defensible claims and track patterns. For payers, the same rules-driven analysis addresses retrospective HCC checks, second-pass QA, prospective risk adjustment and RADV. Pricing is custom/undisclosed, and clinical or financial uplift figures are vendor claims, not independent controlled results.

• Provider revenue-cycle and coding teams reviewing medical notes for missed or unsupported billing codes before claims leave the EHR.
• Payer risk-adjustment teams validating HCC coding, preparing audits, and identifying HEDIS quality gaps.
• Clinical leadership reviewing documentation quality, provider feedback and compliance exceptions rather than sampling only a minority of visits.

Key facts

• Nov 10, 2026 $55M Series B led by Insight Partners with Bain Capital Ventures, Madrona, South Park Commons and QuantumLight participation; valuation undisclosed.
• July 22, 2025 $22M Series A led by Bain Capital Ventures; earlier Feb 2025 $8.1M seed. $85M lifetime is issuer-rounded, versus $85.1M sum of disclosed rounds.
• The company reports 10x revenue growth in 12 months and double-digit denial-rate reductions, but neither audited revenue nor independently controlled improvement estimates were disclosed.

Competitive landscape

Edge: Differentiation claim: a shared evidence-based pre-bill chart interpretation layer serving providers and payers, with configurable specialty and insurer rules, integrated inside EHR workflows. Claims about customer financial gains are company-selected.

In selecting software, a provider should measure accuracy on independently audited specialty-specific charts, unsupported-code false positives, EHR deployment time, human-review volume and denial-rate changes. Payer adoption requires clarity on independence, HIPAA arrangements, training-data handling and audit trails. The $55M raise is venture financing; it does not substantiate revenue or an independently validated 'neutral' common standard.

• Brellium direct

  AI chart-review and billing compliance platform; buyer should compare coverage, specialty rules and auditability.

• Arintra direct

  AI medical coding and revenue-cycle automation; compare human approval and payer-specific rule handling.

• CodaMetrix adjacent

  AI coding workflow automation with different customer/product emphasis.

• Fathom adjacent

  Automated medical coding alternative; breadth of payer/provider audit workflow should be validated separately.

Market / IPO context